Supply of PVMS Drugs for Directorate of Procurement (Navy) Islamabad

The Directorate of Procurement (Navy), Islamabad, invites sealed bids from original manufacturers, authorized distributors, and suppliers registered with income tax and sales tax departments for the supply of PVMS Drugs as per the detailed schedule in DP-2 form. Items being procured include: - PIROXICAM BETA 25 GM TUBE/GEL (400,000 units) - CYCLODEXTRIN HAEMATINIC/VITAMIN TAB/CAP (2,000,000 units) - MULTIVITAMIN TAB/CAP (2,200,000 units) - MULTIVITAMIN (120 ML) SYP/SUSP (130,000 units) The procurement is for Directorate of Procurement (Navy) located at Naval Residential Complex, Sector E-8, Islamabad. The technical scope requires compliance with detailed specifications, including brand names, manufacturer details, and adherence to PVMS/NIV lists. The medicines must have a minimum of 2 years or 70% remaining shelf life at delivery, with exceptions for surgical disposables and lab kits. Delivery period is from 1st July 2027 to 30th June 2028. Inspection will be conducted jointly by Pakistan Navy Medical Stores Depot at Karachi and Islamabad. Eligibility criteria include valid DGDP registration or willingness to register, Active Taxpayers List (ATL) registration with FBR, and submission of earnest money as per category. Firms must submit technical and commercial offers in separate sealed envelopes following the Single Stage Two Envelope bidding procedure. Earnest money must be submitted in a separate sealed envelope with the technical offer. The bids must reach the Directorate of Procurement (Navy) through Bahria Gate, Near SNID Centre, Naval Residential Complex, Sector E-8, Islamabad by 28 October 2026 at 1030 hours. Technical offers will be opened the same day at 1100 hours. A practical tip for bidders: Ensure that all required documents including DGDP registration, FBR certificates, and earnest money are properly attached and that the technical offer strictly follows the format and instructions in Annex-A of DP-2 to avoid rejection. Late or incomplete bids will be rejected outright. This tender offers a significant opportunity for qualified pharmaceutical suppliers to engage with the Pakistan Navy for the supply of essential medicines under a government contract.